Andrew Ko
Academic / Other · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | PEGPH20, Gemicitabine and Nab-Paclitaxel for Pancreatic Ductal Adenocarcinoma Adenocarcinoma | Phase 2 | 2015-07-14 |
| Completed | FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma Pancreatic Cancer, Adenocarcinoma, Pancreatic Neoplasms | Phase 1 | 2011-08-23 |
| Terminated | Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer Pancreatic Cancer | Phase 2 | 2007-01-22 |